In a world of multiplying data and discourse, stakeholders across life sciences and healthcare are increasingly struggling to ...

The future of biopharma – key operational shifts to watch this year ...

With healthcare systems around the world facing unprecedented challenges, now more than ever, there is a need for new, ...

Broadly defined as excess weight that puts an individual at higher risk for adverse health outcomes, obesity is associated ...

Someone said I was ‘ambitious’ and followed up with ‘…they won’t be able to handle you – you’re too much for them’. I was in ...

Growing up in the eighties, I vividly remember the safe sex campaigns that warned of the dangers of HIV/AIDS. The tombstone ...

“Our 10 Year Health Plan will deliver the three big shifts our NHS needs to be fit for the future – from hospital to ...

From a patient’s perspective, the outcome of using the NHS is predominantly some form of medication.

This edition of PharmaTimes is about the radical new look that pharma rocks these days – with it emerging dimensions, ...

Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1 study, showing the survival benefits of ...

Microbiotica, a clinical-stage biopharma company, has presented new data on MB097 at the AACR IO meeting held in Los Angeles.